摘要
<正>1文献来源Attar EC,Johnson JL,Amrein PC,et al.Bortezomib added to Daunorubicin and Cytarabine during induction therapy and to intermediate-dose Cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60to 75 years:CALGB(Alliance)study 10502[J].J Clin Oncol,2013,31...
- 单位